Share Capital - Schedule of Share Based Compensation, Stock Appreciation Rights (Details) - Stock Appreciation Rights (SARs)	12 Months Ended
	Dec. 31, 2024 $ / shares shares
Shares
Beginning balance (in shares) | shares	3,122,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(500,000)
Ending balance (in shares) | shares	2,622,000
Weighted Average Grant Date Fair Value
Weighted average grant date fair value, beginning balance (in dollars per share)	$ 2.59
Weighted average grant date fair value, granted (in dollars per share)	0
Weighted average grant date fair value, exercised (in dollars per share)	3.41
Weighted average grant date fair value, ending balance (in dollars per share)	2.44
Weighted Average Exercise Price
Weighted average exercise price, beginning balance (in dollars per share)	5.74
Weighted average exercise price, granted (in dollars per share)	0
Weighted average exercise price, exercised (in dollars per share)	2.19
Weighted average exercise price, ending balance (in dollars per share)	$ 6.42
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares	2,500,000